What does Zhejiang Xinguang Pharmaceutical Co., Ltd. do?

Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 300519.SZ's market cap?

Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) has a market capitalization of approximately $2.40 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 300519.SZ pay a dividend?

Yes — Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) pays a dividend annually, with a trailing-twelve-month yield of 2.00%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

300519.SZ

Zhejiang Xinguang Pharmaceutical Co., Ltd.

SHZ·Medical, Pharmaceuticals · Healthcare

¥15.00¥0.26−1.70%

Market cap¥2.40B·Market closed·Aug 26 7:04 AM UTC

Price Chart

¥15.00−¥0.26 (−1.70%)today

−8.14%CAGR −1.69%

Select date range

FromTo

Jun 24, 2016Aug 27, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)2.00%

Annual Dividend (FWD)¥0.30

Dividend Growth (5Y)−12.9%

Dividend Safety—

Payout Ratio85.6%

FCF Payout Ratio61.9%

Most Recent Dividend¥0.300

Ex-Dividend DateMay 29

Payment DateMay 29

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)+7.7%

EPS Growth (3Y)−17.0%

EPS Growth (5Y)−13.1%

Next Earnings DateMay 16

Last Report DateApr 20

Reported vs Estimate¥0.16

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥260.58M

Net Income¥56.04M

Net Margin21.5%

Operating Cash Flow¥82.55M

Capital Expenditures¥2.69M

Free Cash Flow¥79.86M

Return on Equity6.5%

Return on Invested Capital3.0%

Net Cash¥771.53M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 300519.SZ and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 300519.SZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 300519.SZ and 80,000+ other tickers.

About Zhejiang Xinguang Pharmaceutical Co., Ltd.

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China.

CEO: Yue Jun Wang
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: SHZ
Employees: 309
Website: www.xgpharma.com

Peers

Peers Tab

002817.SZ

Anhui Huangshan Capsule Co., Ltd.

Cap

¥2.0B

600080.SS

Ginwa Enterprise (Group) Inc.

Cap

¥1.8B

000790.SZ

Chengdu Huasun Technology Group Inc., Ltd.

Cap

¥2.6B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 300519.SZ

What does Zhejiang Xinguang Pharmaceutical Co., Ltd. do?: Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 300519.SZ's market cap?: Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) has a market capitalization of approximately $2.40 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 300519.SZ pay a dividend?: Yes — Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) pays a dividend annually, with a trailing-twelve-month yield of 2.00%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.